Abstract

Introduction: The purpose of this study was to evaluate the diagnostic role of postmortem pericardial fluid cardiac troponins in cases of sudden cardiac death and to determine its significance.

Methods: This study included totally 30 cases, of which 23 were cases of sudden cardiac death and 7 were control cases. In the following cases, along with age, gender, as well as circumstance of death, level of cardiac troponin I In pericardial fluid, cytological analysis of the fluid as well as post mortem findings of the coronary arteries were all analyzed. Levels of troponin I were assessed with the help of a rapid card test which worked on the principle of sandwich immunoassay. It detects a minimum amount of 0.5ng/ml of cTnI in samples.

Results: In the 30 cases among which the study was conducted, the mean age was 44 years of age, with the majority of the cases lying between the ages of 41–50 (37%). It was also found that the majority of them were males (86.7%) as compared to females (13.3%). The mean time interval between death and sample testing came up to 11 hours, with the majority of the cases being between 16–20 hours time interval (37%). On correlation of rapid card test results and gross post mortem findings, the test showed a sensitivity of 86.7% and specificity of 20%.

Conclusion: From statistical analysis it could be inferred that the frequency of MI was more in males than females, and in the age group of 41–50. The rapid card test had an appreciable sensitivity, but the specificity inferred there could be various situations in which there could be elevated troponins in pericardial fluid. This infers that while a case of myocardial infarction has a higher chance of showing elevated levels of cardiac troponin in pericardial fluid, a case of sudden death can not be reliably diagnosed as AMI on the basis of elevated troponins alone. There must be correlation between clinical, histopathological and cardiac marker findings.

• 1.   Bolooki HM, Askari A. Acute myocardial infarction. In: Current Clinical Medicine. 2nd ed. Philadelphia: Saunders Elsevier; 2010. p. 65–71.
• 2.   Neglia D, Rovai D, Caselli C, Pietila M, et al. Detection of Significant Coronary Artery Disease by Noninvasive Anatomical and Functional Imaging. Circ Cardiovasc Imaging. 2015;8:e002179.
• 3.   Ambrose JA. In search of the vulnerable plaque. J Am Coll Cardiol. 2008 Apr;51(16):1539–42.
• 4.   Cao Z, Zhao M, Xu C, et al. Diagnostic Roles of Postmortem cTnI and cTnT in Cardiac Death with Special Regard to Myocardial Infarction: A Systematic Literature Review and Meta-Analysis. Int J Mol Sci. 2019 Jul 8;20(13):3351.
• 5.   Taqueti VR, Di Carli MF. Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018;72(21):2625–41.
• 6.   White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol. 2011;57(24):2406–8.
• 7.   Al-Hadi HA, Fox KA. Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome. Sultan Qaboos Univ Med J. 2009;9(3):231–46.
• 8.   Conrad MJ, Jarolim P. Cardiac troponins and high-sensitivity cardiac troponin assays. Clin Lab Med. 2014 Mar;34(1):59–73.
• 9.   Zhu BL, Ishikawa T, Michiue T, et al. Postmortem cardiac troponin I and creatine kinase MB levels in the blood and pericardial fluid as markers of myocardial damage in medicolegal autopsy. Leg Med (Tokyo). 2007 Sep;9(5):241–50.
• 10.   Davies SJ, Gaze DC, Collinson PO. Investigation of cardiac troponins in postmortem subjects: comparing antemortem and postmortem levels. Am J Forensic Med Pathol. 2005 Sep;26(3):213–5.
• 11.   Fox WR, Diercks DB. Troponin assay use in the emergency department for management of patients with potential acute coronary syndrome: current use and future directions. Clin Exp Emerg Med. 2016 Mar 31;3(1):1–8.
• 12.   Barberi C, van den Hondel KE. The use of cardiac troponin T (cTnT) in the postmortem diagnosis of acute myocardial infarction and sudden cardiac death: A systematic review. Forensic Sci Int. 2018 Nov 1;292:27–38.
• 13.   Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36(3):959–69.
• 14.   Zhu BL, Ishikawa T, Michiue T, et al. Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 2: analysis for application in the diagnosis of sudden cardiac death with regard to pathology. Leg Med (Tokyo). 2006 Mar 1;8(2):94–101.